Obstructing FDA inspections
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Obstructing FDA inspections
-
Lu par :
-
De :
À propos de ce contenu audio
This episode outlines official FDA guidance regarding the specific behaviors that constitute the obstruction of drug or device inspections. Under federal law, if a facility delays, denies, limits, or refuses an inspection, the products manufactured there are legally considered adulterated. Prohibited actions include failing to schedule pre-announced visits, withholding records, and restricting access to operational areas or photography. While the agency considers legitimate justifications for certain disruptions, such as safety protocols or language barriers, it maintains broad authority to ensure regulatory compliance.
#FDA #RegulatoryCompliance #FDAInspection #Pharma #MedicalDevices #FDALaw #QualityAssurance #AuditReady #LifeSciences #Compliance
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !